Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Location sections listing sites in Arkansas, Connecticut, Florida, Georgia, Missouri, New York, Ohio, South Carolina, Tennessee, Hainaut (Belgium), and Cluj (Romania); removed the previous location blocks, and updated the revision to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-17T20:00:37.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; this change does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:48:44.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The funding/operational status notice was removed from the page; the page now displays the study details without that alert.
    Difference
    0.3%
    Check dated 2025-11-19T08:25:30.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The new screenshot shows no substantive changes to the study details. Core information such as eligibility criteria, locations, and planned outcomes remains the same.
    Difference
    0.3%
    Check dated 2025-10-28T05:20:14.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T16:07:33.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:09:01.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.